Cardiac stem cell therapy for cardiac repair

Current Treatment Options in Cardiovascular Medicine

Volumn 16, Issue 7, 2014, Pages

  Hong, Kyung U ^a   Bolli, Roberto ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cardiac repair; Ischemic cardiomyopathy; Myocardial infarction; Stem cell therapy

Indexed keywords

STEM CELL FACTOR;

CARDIAC STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL RENEWAL; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; ISCHEMIC CARDIOMYOPATHY; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; STEM CELL TRANSPLANTATION; SURVIVAL;

EID: 84901734147     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-014-0324-3     Document Type: Review

References (100)

1. Go AS et al. Heart disease and stroke statistics - 2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6-245.
2. Sanganalmath SK, Bolli R. Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res. 2013;113(6):810-34.
3. Beltrami AP et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114(6):763-76. (Pubitemid 37186770)
4. Rumyantsev PP. Interrelations of the proliferation and differentiation processes during cardiact myogenesis and regeneration. Int Rev Cytol. 1977;51:186-273.
5. Cameron IL, Thrasher JD. Cellular and molecular renewal in the mammalian body. In: Cell biology. New York: Academic Press; 1971. p. xiv. 418 p.
6. Rumery RE, Rieke WO. DNA synthesis by cultured myocardial cells. Anat Rec. 1967;158(4):501-7.
7. Shafiq SA, Gorycki MA, Mauro A. Mitosis during postnatal growth in skeletal and cardiac muscle of the rat. J Anat. 1968;103(Pt 1):135-41.
8. Hsieh PC et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med. 2007;13(8):970-4. (Pubitemid 47222045)
9. Sohal DS et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res. 2001;89(1):20-5. (Pubitemid 34135487)
10. Novak A et al. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis. 2000;28(3-4):147-55.
11. Morrison SJ et al. Identification of a lineage of multipotent hematopoietic progenitors. Development. 1997;124(10):1929-39. (Pubitemid 27270262)
12. Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol. 2001;17:387-403. (Pubitemid 33096181)
13. Bearzi C et al. Human cardiac stem cells. Proc Natl Acad Sci U S A. 2007;104(35):14068-73. (Pubitemid 350003336)
14. Linke A et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A. 2005;102(25):8966-71. (Pubitemid 40881062)
15. Urbanek K et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A. 2006;103(24):9226-31. (Pubitemid 43902560)
16. Anversa P et al. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation. 2006;113(11):1451-63. (Pubitemid 43739442)
17. Bearzi C et al. Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A. 2009;106(37):15885-90.
18. Yang L et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008;453(7194):524-8. (Pubitemid 351733312)
19. Wang X et al. The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells. 2006;24(7):1779-88. (Pubitemid 44474191)
20. Oh H et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003;100(21):12313-8. (Pubitemid 37271557)
21. Hierlihy AM et al. The post-natal heart contains a myocardial stem cell population. FEBS Lett. 2002;530(1-3):239-43. (Pubitemid 35248218)
22. Pfister O et al. CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res. 2005;97(1):52-61. (Pubitemid 40982322)
23. Oyama T et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol. 2007;176(3):329-41. (Pubitemid 46184884)
24. Messina E et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004;95(9):911-21. (Pubitemid 39435006)
25. Smith RR et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007;115(7):896-908. (Pubitemid 46294730)
26. Johnston PV et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation. 2009;120(12):1075-83. 7 p following 1083.
27. Wessels A, Perez-Pomares JM. The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells. Anat Rec A: Discov Mol Cell Evol Biol. 2004;276(1):43-57. (Pubitemid 38063877)
28. Smart N et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature. 2011;474(7353):640-4.
29. Dey D et al. Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ Res. 2013;112(9):1253-62.
30. Ferreira-Martins J et al. Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells. Circ Res. 2012;110(5):701-15.
31. Quaini F et al. Chimerism of the transplanted heart. N Engl J Med. 2002;346(1):5-15. (Pubitemid 34438914)
32. Muller P et al. Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation. 2002;106(1):31-5. (Pubitemid 34747438)
33. Thiele J et al. Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stemcell transplantation in comparison with cardiac allografts. Transplantation. 2004;77(12):1902-5. (Pubitemid 38822217)
34. Deb A et al. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation. 2003;107(9):1247-9. (Pubitemid 36314405)
35. Fazel S et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest. 2006;116(7):1865-77. (Pubitemid 44033311)
36. Fujita J et al. Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. Stem Cells. 2007;25(11):2750-9. (Pubitemid 350127859)
37. Wang Y et al. Evidence for ischemia induced host-derived bone marrow cell mobilization into cardiac allografts. J Mol Cell Cardiol. 2006;41(3):478-87. (Pubitemid 44349132)
38. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008;451(7181):937-42. (Pubitemid 351301749)
39. .• Ellison GM et al. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell. 2013;154(4):827-42. This study used a reversible myocardial injury model in conjuction with different genetic approaches to examine the contribution of endogenous c-kit+ cardiac stem cells to myocardial renewal. Using a genetic fate mapping approach to demonstrate that new cardiomyocytes originate from endogenous c-kit+ cardiac stem cells via direct differentiation.
40. .•• Bolli R et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011;378(9806):1847-57. This is the first interim report on the phase I clinical trial (SCIPIO) of c-kit+/Lin- cardiac stem cells.
41. .• Tang XL et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation. 2010;121(2):293-305. This study demonstrated that infusion of c-kit+/Lin- cardiac stem/progenitor cells is effective in improving the cardiac functions in a more clinically relevant setting using a chronic myocardial infarction model.
42. Li Q, et al. Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models. Basic Res Cardiol. 2011.
43. Rota M et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res. 2008;103(1):107-16.
44. .• Bolli R et al. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation. 2013;128(2):122-31. This study examined the therapeutic efficacy of c-kit/Lin-cardiac stem cells using a preclinical large animal model of ischemic cardiomyopathy.
45. Williams AR et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation. 2013;127(2):213-23.
46. Mohsin S et al. Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. J Am Coll Cardiol. 2012;60(14):1278-87.
47. Rota M et al. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res. 2006;99(1):42-52. (Pubitemid 44297054)
48. Kajstura J et al. Cardiac stem cells and myocardial disease. J Mol Cell Cardiol. 2008;45(4):505-13.
49. De Angelis A et al. Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation. 2010;121(2):276-92.
50. Rona G et al. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol. 1959;67(4):443-55.
51. Joyner AL, Zervas M. Genetic inducible fate mapping in mouse: establishing genetic lineages and defining genetic neuroanatomy in the nervous system. Dev Dyn. 2006;235(9):2376-85. (Pubitemid 44325253)
52. Srinivas S et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol. 2001;1:4.
53. Chong JJ et al. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell. 2011;9(6):527-40.
54. Senyo SE et al. Mammalian heart renewal by preexisting cardiomyocytes. Nature. 2013;493(7432):433-6.
55. + cells minimally contribute cardiomyocytes to the heart. Nature. 2014;509(7500):337-41.
56. Fischer KM et al. Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation. 2009;120(21):2077-87.
57. Angert D et al. Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells. Circ Res. 2011;108(10):1226-37.
58. Dawn B et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A. 2005;102(10):3766-71. (Pubitemid 40354686)
59. .•• Chugh AR et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation. 2012;126(11 Suppl 1):S54-64. This report provides more updated information on the progress of the SCIPIO trial and includes MRI-based analysis of cardiac stem cell-treated patients
60. Tang YL et al. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol. 2005;46(7):1339-50. (Pubitemid 41615559)
61. Laflamme MA et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol. 2005;167(3):663-71. (Pubitemid 41216352)
62. Reinecke H et al. Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation. 1999;100(2):193-202. (Pubitemid 29330019)
63. Toma C et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105(1):93-8. (Pubitemid 34049148)
64. Robey TE et al. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol. 2008;45(4):567-81.
65. Schachinger V et al. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation. 2008;118(14):1425- 32.
66. Haider H, Ashraf M. Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol. 2008;45(4):554-66.
67. Hong KU et al. A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice. Basic Res Cardiol. 2013;108(3):346.
68. Forrester JS, Libby P. The inflammation hypothesis and its potential relevance to statin therapy. Am J Cardiol. 2007;99(5):732-8.
69. Penn MS, Mangi AA. Genetic enhancement of stem cell engraftment, survival, and efficacy. Circ Res. 2008;102(12):1471-82.
70. Ma K et al. A Y chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis. Cell. 1993;75(7):1287-95. (Pubitemid 24021904)
71. Chai NN et al. Structure and organization of the RBMY genes on the human Y chromosome: transposition and amplification of an ancestral autosomal hnRNPG gene. Genomics. 1998;49(2):283-9.
72. Muraski JA et al. Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med. 2007;13(12):1467-75. (Pubitemid 350224243)
73. Wang Z et al. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J Vet Sci. 2001;2(3):167-79.
74. Wu JC et al. Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation. 2003;108(11):1302-5. (Pubitemid 37174406)
75. Cottage CT et al. Increased mitotic rate coincident with transient telomere lengthening resulting from pim-1 overexpression in cardiac progenitor cells. Stem Cells. 2012;30(11):2512-22.
76. Xu M, Millard RW, Ashraf M. Role of GATA-4 in differentiation and survival of bone marrow mesenchymal stem cells. Prog Mol Biol Transl Sci. 2012;111:217-41.
77. Huang W et al. Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9. Stem Cells Dev. 2012;21(5):778-89.
78. Mangi AA et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med. 2003;9(9):1195-201. (Pubitemid 37173705)
79. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev. 1999;13(22):2905-27.
80. Fujio Y et al. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000;101(6):660-7. (Pubitemid 30094738)
81. Melo LG et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation. 2002;105(5):602-7. (Pubitemid 34123435)
82. Vulapalli SR et al. Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. Am J Physiol Heart Circ Physiol. 2002;283(2):H688-94. (Pubitemid 34790864)
83. McGinley LM et al. Mesenchymal stem cell survival in the infarcted heart is enhanced by lentivirus vector-mediated heat shock protein 27 expression. Hum Gene Ther. 2013;24(10):840-51.
84. Huang F et al. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction. Cardiology. 2013;125(1):18-30.
85. Wang L et al. Protein kinase G1 alpha overexpression increases stem cell survival and cardiac function after myocardial infarction. PLoS ONE. 2013;8(3):e60087.
86. Shan Y et al. Induction of the heme oxygenase-1 gene by metalloporphyrins. Arch Biochem Biophys. 2000;380(2):219-27. (Pubitemid 30659090)
87. Cai C et al. The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release. J Biol Chem. 2012;287(40):33720-32.
88. Ngoh GA et al. O-GlcNAc signaling in the cardiovascular system. Circ Res. 2010;107(2):171-85.
89. Zafir A et al. Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells. Stem Cells. 2013;31(4):765-75.
90. Ye L et al. Thymosin beta4 Increases the potency of transplanted mesenchymal stem cells for myocardial repair. Circulation. 2013;128(26 Suppl 1):S32-41.
91. Iso Y, et al. Priming with ligands secreted by human stromal progenitor cells promotes grafts of cardiac stem/progenitor cells after myocardial infarction. Stem Cells. 2013.
92. Herrmann JL et al. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock. 2010;33(1):24-30.
93. Penna C et al. Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival. J Cell Mol Med. 2013;17(1):192-204.
94. Pendergrass KD et al. Acute preconditioning of cardiac progenitor cells with hydrogen peroxide enhances angiogenic pathways following ischemia-reperfusion injury. Stem Cells Dev. 2013;22(17):2414-24.
95. Gnecchi M et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103(11):1204-19.
96. Mirotsou M et al. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol. 2011;50(2):280-9.
97. Ebelt H et al. Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells. 2007;25(1):236-44. (Pubitemid 46052995)
98. Chimenti I et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res. 2010;106(5):971-80.
99. Yoon CH et al. Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: role of cardiovascular lineage commitment. Circulation. 2010;121(18):2001-11.
100. • Behfar A et al. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol. 2010;56(9):721-34. This study showed that donor MSCs can be successfully primed or guided ex vivo to become cardiogenic, and that cardiogenic MSCs exhibit superior therapeutic efficacy against ischemic cardiomyopathy.